During the last year, the landscape of the legal cannabis market in the United States (US) has shifted. When the market became focused on the cannabis sector, Canada and the west coast of the US were in high focus.

A few years ago, we noticed a shift in the domestic cannabis industry and identified increasing interest in cannabis markets on the east coast of the US. From Florida to Massachusetts, we are favorable to the limited license structure of most cannabis markets on the east coast. We prefer this structure to certain markets on the west coast of the US which can issue an unlimited number of licenses.

The most recent shift in the US cannabis market is related to markets in the Midwest and we are bullish on the growth prospects that are associated with this region. Some of the high-profile markets in the Midwest include Illinois, Michigan, and Ohio. Over the next year, we expect to see more markets in the Midwest mature into significant opportunities for companies and investors.

Last week, we highlighted Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) is a multi-state operator (MSOs) that we are bullish on due its focus on burgeoning medical and recreational cannabis markets in the US.

Focused on High-Profile US Cannabis Markets

From a geographic strategy standpoint, we are favorable on the states that Body and Mind has targeted and believe these regions are attractive long-term growth markets. We are impressed with how the management team has expanded the operation and grew from being a west coast focused operator.

From an expansion standpoint, 2021 has been a banner year for Body and Mind. We are bullish on the leverage that it has to both Michigan and Ohio and consider these states to be attractive limited license cannabis markets.

The company’s management team is highly focused on penetrating burgeoning cannabis markets and capturing market share.

An Attractive Growth Story that is Trading for a Discount

Since inception, we believe that Body and Mind has done a great job at creating a brand that has strong consumer demand. We are of the opinion that the business is nearing an inflection point as it relates to growth and consider it to be an under-appreciated opportunity.

Going forward, we believe the management team has the business well positioned to report ramping revenues and improving profitability. We classify Body and Mind as a business that has substantial catalysts for growth and believe that our readers need to be aware of the opportunity.

At current levels, we find the valuation to be attractive and believe that Body and Mind has a favorable risk-reward profile. We are of the opinion that there is a disconnect with the market and consider Body and Mind to be a unique growth story.

If you are interested in learning more about Body and Mind, please send an email to support@technical420.com with the subject “Body and Mind” to be added to our distribution list.

For the fastest access to data on Body and Mind, sign up for our free newsletter!

Pursuant to an agreement between StoneBridge Partners LLC and Body and Mind Inc. we have been hired for a period of 90 days beginning October 1, 2021 to publicly disseminate information about (BAMM) including on the Website and other media including Facebook and Twitter. We are being paid $5,000 per month (BAMM) for or were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of (BAMM) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (BAMM) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.